Literature DB >> 20006564

Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: similar metabolic profiles in liver and intestine of rats.

Cheng-Feng Luo1, Mu Yuan, Min-Sheng Chen, Shi-Ming Liu, Hong Ji.   

Abstract

Puerarin is a major active ingredient of Pueraria radix. Puerarin may exert its medicinal functions in part via its metabolites. In this study, we identified these metabolites to better understand and elucidate puerarin's metabolic pathway. Puerarin was intravenously administered to rats and then metabolites in plasma samples were identified by rapid resolution liquid chromatography electrospray ionization-collision induced dissociation tandem mass spectrometry (RRLC-ESI-CID-MS/MS). Chromatography was conducted on a Zorbax SB C18 column (2.1x100 mm, 1.8 microm) at 30 degrees C, with a gradient mobile phase consisting of 0.05% formic acid and acetonitrile, a flow rate of 0.2 mL min(-1), and a total run time of 14 min. MS/MS acquisition parameters were as follows: positive ionization mode, dry gas: nitrogen, 10 L min(-1), dry temperature: 350 degrees C, nebulizer: 40 psi, capillary: -3500 V, scan range: 250-800. The autoMS, manual, or multiple reaction monitoring mode was selected as required. Two glucuronidated metabolites of puerarin (M1 and M2) were detected. M1 and M2 are presumed to be puerarin-7-O-glucuronide and puerarin-4'-O-glucuronide, respectively, and M2 likely is suspected to be the major metabolite because it represented the predominate peak. Kinetic studies of metabolites demonstrated that M1 and M2 were detected in rat plasma at 5 min after intravenous administration of puerarin, the levels of M1 and M2 then reached their peaks at 10-15 and 15-30 min, respectively. The metabolic profiles were similar in rat liver and intestine investigated by in situ liver and intestine perfusion, indicating that no metabolic regioselectivity of puerarin occurs in the two organs. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006564     DOI: 10.1016/j.jchromb.2009.12.002

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  11 in total

1.  Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress.

Authors:  Ning Hou; Bin Cai; Cai-Wen Ou; Zhen-Hui Zhang; Xia-Wen Liu; Mu Yuan; Gan-Jian Zhao; Shi-Ming Liu; Long-Gen Xiong; Jian-Dong Luo; Cheng-Feng Luo; Min-Sheng Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-16       Impact factor: 3.000

2.  Increased puerarin biosynthesis during in vitro shoot formation in Pueraria tuberosa grown in growtek bioreactor with aeration.

Authors:  Varsha Sharma; Shaily Goyal; Kishan G Ramawat
Journal:  Physiol Mol Biol Plants       Date:  2011-01-20

3.  Absolute oral bioavailability and disposition kinetics of puerarin in female rats.

Authors:  Tosapol Anukunwithaya; Pilaslak Poo; Natthaphon Hunsakunachai; Ratchanee Rodsiri; Suchinda Malaivijitnond; Phisit Khemawoot
Journal:  BMC Pharmacol Toxicol       Date:  2018-05-25       Impact factor: 2.483

4.  Pharmacokinetics and Tissue Distribution Kinetics of Puerarin in Rats Using Indirect Competitive ELISA.

Authors:  Hui Kong; Xueqian Wang; Rongfeng Shi; Yan Zhao; Jinjun Cheng; Xin Yan; Xiaoman Liu; Yongzhi Wang; Meiling Zhang; Qingguo Wang; Huihua Qu
Journal:  Molecules       Date:  2017-06-05       Impact factor: 4.411

5.  Comparative Pharmacokinetic Profiles of Puerarin in Rat Plasma by UHPLC-MS/MS after Oral Administration of Pueraria lobata Extract and Pure Puerarin.

Authors:  Guozhe Zhang; Jianwei Ji; Mingzhong Sun; Yuqiao Ji; Hongjian Ji
Journal:  J Anal Methods Chem       Date:  2020-04-14       Impact factor: 2.193

Review 6.  Molecular Mechanisms of Anticancer Activities of Puerarin.

Authors:  Bashir Ahmad; Suliman Khan; Yang Liu; Mengzhou Xue; Ghulam Nabi; Sunjeet Kumar; Mohammed Alshwmi; Abdul Wakeel Qarluq
Journal:  Cancer Manag Res       Date:  2020-01-08       Impact factor: 3.989

7.  The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.

Authors:  Hengyue Zhu; Yanyi Xiao; Hangcheng Guo; Yangyang Guo; Youze Huang; Yunfeng Shan; Yongheng Bai; Xiangyang Lin; Hong Lu
Journal:  Aging (Albany NY)       Date:  2021-12-04       Impact factor: 5.682

Review 8.  Protective effect of isoflavones and triterpenoid saponins from pueraria lobata on liver diseases: A review.

Authors:  Heng He; Shuwei Peng; Xu Song; Renyong Jia; Yuanfeng Zou; Lixia Li; Zhongqiong Yin
Journal:  Food Sci Nutr       Date:  2021-12-10       Impact factor: 2.863

9.  Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles.

Authors:  Cheng-Feng Luo; Ning Hou; Juan Tian; Mu Yuan; Shi-Ming Liu; Long-Gen Xiong; Jian-Dong Luo; Min-Sheng Chen
Journal:  Int J Nanomedicine       Date:  2013-03-04

Review 10.  Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine.

Authors:  Liang Zhang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.